Yet, the role of the NLRP3 inflammasome in IBD is controversial, with some studies reporting detrimental outcomes of NLRP3 activation while others suggested cell-protective effects (reviewed in [12,13]). The gene discussed is NLRP3; the disease is irritable bowel syndrome.